HA35 treatment for chronic skin inflammation
35 kDa Hyaluronan Fragment (HA35) Reduces Chronic Skin Inflammation
This study is testing if a new skin treatment using HA35 injections can help people with chronic skin inflammation and other skin issues feel better and look healthier.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Nakhia Impex LLC Industry-sponsored |
| Locations | 1 site (Ulaanbaatar) |
| Trial ID | NCT06387212 on ClinicalTrials.gov |
What this trial studies
This study investigates the clinical effects and safety of a 35 kDa hyaluronic acid fragment (HA35) combined with negative pressure microneedle technology to address various skin issues, including chronic inflammation and pigmentation. Participants will receive injections of HA35 to evaluate improvements in skin conditions such as dryness, pore size, and erythema. The study aims to determine the efficacy of this innovative approach in enhancing skin health and appearance.
Who should consider this trial
Good fit: Ideal candidates include individuals suffering from chronic skin inflammation, dryness, and pigmentation issues.
Not a fit: Patients who are pregnant, lactating, or have hypersensitivity to hyaluronic acid may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve skin conditions related to chronic inflammation and enhance overall skin quality.
How similar studies have performed: While this approach is innovative, there is limited information on the success of similar studies involving HA35 and microneedle technology.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Skin problems include but are not limited to dry skin, dark skin, and coarse pores. * Chronic skin inflammation, pigmentation, erythema, etc. * Cooperate with the experimental requirements and be able to complete the score independently。 Exclusion Criteria: * Pregnant or lactating women. * Suffering from psychological or mental illness. * Life is not regular, overeating. * Hypersensitive to hyaluronic acid, and has a scar constitution.
Where this trial is running
Ulaanbaatar
- Nahia Impex LLC — Ulaanbaatar, Mongolia (Recruiting)
Study contacts
- Study coordinator: Mizhou Hui
- Email: mizhou.hui@alumni.utoronto.ca
- Phone: 13484005199
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.